Clinical Trial Update: Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 trial examining safety and efficacy of bexagliflozin in subjects with moderate hepatic impairment; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bexagliflozin (null)

Snippet

Sponsor: Theracos | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2021-05-07